Abstract
Candida tropicalis is a diploid ascomycetes yeast responsible for 4%-24% of candidemia. Resistance to flucytosine is rarely described for this species but was observed for 45 (35%) of 130 C. tropicalis isolates recovered from blood cultures in the Paris area in a 4-year survey. The aims of this study were to test the hypothesis that the flucytosine-resistant isolates could represent a subgroup and to determine the relationship between epidemiologic and genomic data. Epidemiologic data and gene sequences were analyzed, and molecular typing was performed. Our results suggest that a clone of flucytosine-resistant isolates, associated with malignancies and a lower mortality than that for other C. tropicalis isolates, is widespread in the Paris area. We propose the analysis of 2 polymorphic microsatellite markers coupled with URA3 sequencing to track the clone.
Original language | English |
---|---|
Pages (from-to) | 557-65 |
Number of pages | 9 |
Journal | Emerging Infectious Diseases |
Volume | 14 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2008 |
Keywords
- Antifungal Agents
- Candida tropicalis
- Candidiasis
- Drug Resistance, Fungal
- Flucytosine
- France
- Fungemia
- Genotype
- Humans
- Microsatellite Repeats
- Phenotype
- Risk Factors
- Time Factors